| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |